KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pitney Bowes (PBI) Cash & Equivalents (2016 - 2025)

Pitney Bowes (PBI) has disclosed Cash & Equivalents for 17 consecutive years, with $321.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 42.84% to $321.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $321.0 million, a 42.84% decrease, with the full-year FY2024 number at $469.7 million, down 21.72% from a year prior.
  • Cash & Equivalents was $321.0 million for Q3 2025 at Pitney Bowes, up from $285.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $799.5 million in Q2 2021 to a low of $285.2 million in Q2 2025.
  • A 5-year average of $562.0 million and a median of $570.7 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: increased 8.94% in 2024, then plummeted 51.68% in 2025.
  • Pitney Bowes' Cash & Equivalents stood at $732.5 million in 2021, then fell by 8.76% to $668.3 million in 2022, then fell by 10.22% to $600.1 million in 2023, then decreased by 21.72% to $469.7 million in 2024, then plummeted by 31.66% to $321.0 million in 2025.
  • Per Business Quant, the three most recent readings for PBI's Cash & Equivalents are $321.0 million (Q3 2025), $285.2 million (Q2 2025), and $323.8 million (Q1 2025).